Alterity Therapeutics

$1.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.78%) As of 1:04 PM UTC pre-market

Why Robinhood?

You can buy or sell ATHE and other stocks, options, and ETFs commission-free!

About ATHE

Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders.

CEO
David A. Stamler
Employees
12
Headquarters
Melbourne, Victoria (VIC)
Founded
1997
Market Cap
45.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
149.54K
High Today
$1.37
Low Today
$1.25
Open Price
$1.36
Volume
331.75K
52 Week High
$5.15
52 Week Low
$0.55

ATHE Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 17, Pre-Market

You May Also Like

PHAS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure